3QTU
CDK2 in complex with inhibitor RC-2-132
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 93 |
Detector technology | CCD |
Collection date | 2010-05-12 |
Detector | RIGAKU SATURN 944+ |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 53.723, 71.958, 72.939 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 23.120 - 1.820 |
R-factor | 0.195 |
Rwork | 0.195 |
R-free | 0.24600 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1pw2 |
RMSD bond length | 0.008 |
RMSD bond angle | 1.400 |
Data reduction software | DENZO |
Phasing software | CNS (1.2) |
Refinement software | CNS (1.2) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 23.120 | 1.850 |
High resolution limit [Å] | 1.820 | 1.820 |
Rmerge | 0.053 | 0.364 |
Number of reflections | 25332 | |
<I/σ(I)> | 54.4 | 5.95 |
Completeness [%] | 97.4 | 91.4 |
Redundancy | 5.8 | 3.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 7.5 | 291 | 5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K |